Improving housing affordability will significantly reduce homelessness, but it will not in itself solve the problem.

Despite its exciting potential, esketamine is receiving significantly more attention for being similar to the street drug ketamine.

The FDA has granted MDMA breakthrough therapy status to expedite the approval process by making it easier for drugmakers to begin clinical trials.